Bayer: New innovation Leader
06.03.2014 - Kemal Malik (51) has been appointed to the Board of Bayer AG.
Malik has been a member of the Bayer HealthCare Executive Committee and its Head of Global Development and Chief Medical Officer since 2007. He is to succeed Prof. Wolfgang Plischke, who is retiring. In his new position, Malik will be responsible for innovation, and is taking over responsibility for the North America region. Before joining Bayer in 1995, the physician held various positions of increasing responsibility at Bristol-Myers Squibb. At Bayer, he served as Head of Global Medical Development before being appointed Head of Global Development.